Your email has been successfully added to our mailing list.

×
0 0.00474708171206236 -0.0327626459143968 -0.0116731517509728 -0.045136186770428 -0.0263813229571984 -0.0116731517509728 -0.0154863813229572
Stock impact report

AnaptysBio's lead candidate shows positive effect in mid-stage peanut allergy study; shares ahead 7% after hours [Seeking Alpha]

AnaptysBio, Inc. (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
Company Research Source: Seeking Alpha
AnaptysBio's lead candidate shows positive effect in mid-stage peanut allergy study; shares ahead 7% after hoursAnaptysBio (NASDAQ:ANAB) is up7% after hours on the heels of itsannouncement of positive preliminary results from a Phase 2a proof-of-concept clinical trial assessing lead drug ANB020 in adult patients with peanut allergy.After a single intravenous dose of ANB020 46% (n=6/13) patients exhibiting moderate-to-severe symptoms during a baseline oral food challenge at enrollment improved peanut tolerance to a cumulative 500 mg at day 14 compared to 0% (n=0/3) for placebo.Detailed data will be submitted for presentation at a future medical conference.ANB020 is an antibody that binds to the pro-inflammatory cytokine interleukin 33 (IL-33), a protein that plays a key role in atopic diseases, including asthma, food allergies and atopic dermatitis.Management will host a conference call today at 5:00 pm ET to discuss the results.Previously:AnaptysBio's lead candidate ANB020 shows treat Show less Read more
Impact Snapshot
Event Time:
ANAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ANAB alerts

from News Quantified
Opt-in for
ANAB alerts

from News Quantified